We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.64B
AUM Growth
-$549M
Cap. Flow
-$740M
Cap. Flow %
-15.94%
Top 10 Hldgs %
18.26%
Holding
2,053
New
548
Increased
435
Reduced
586
Closed
465

Sector Composition

Rank Sector Weight
1 Technology 14.84%
2 Communication Services 14.33%
3 Consumer Discretionary 13.23%
4 Healthcare 10.58%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITIC
1451
Investors Title Co
ITIC
$546M
$205K ﹤0.01%
994
-190
-16% -$36.5K
FSBW icon
1452
FS Bancorp
FSBW
$323M
$204K ﹤0.01%
+7,458
New +$205K
KBAL
1453
DELISTED
Kimball International
KBAL
$204K ﹤0.01%
10,851
-18,095
-63% -$342K
SAR icon
1454
Saratoga Investment
SAR
$311M
$202K ﹤0.01%
+9,056
New +$201K
NAV
1455
DELISTED
Navistar International
NAV
$202K ﹤0.01%
4,706
-9,769
-67% -$406K
AGX icon
1456
Argan
AGX
$8.44B
$200K ﹤0.01%
+4,381
New +$261K
STAY
1457
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$198K ﹤0.01%
10,440
-5,542
-35% -$103K
CLAR icon
1458
Clarus
CLAR
$129M
$197K ﹤0.01%
25,025
-21,007
-46% -$158K
CDTX
1459
DELISTED
Cidara Therapeutics
CDTX
$196K ﹤0.01%
1,449
+340
+31% +$51.6K
ACGN
1460
DELISTED
Aceragen Inc
ACGN
$195K ﹤0.01%
+674
New +$192K
HCAP
1461
DELISTED
Harvest Capital Credit Corporation
HCAP
$192K ﹤0.01%
+17,431
New +$213K
KND
1462
DELISTED
Kindred Healthcare
KND
$192K ﹤0.01%
20,108
-16,982
-46% -$126K
MCBC
1463
DELISTED
Macatawa Bank Corp
MCBC
$190K ﹤0.01%
18,940
+4,040
+27% +$40.7K
INO icon
1464
Inovio Pharmaceuticals
INO
$70M
$189K ﹤0.01%
3,722
-6,812
-65% -$422K
LAB icon
1465
Standard BioTools
LAB
$307M
$184K ﹤0.01%
+30,513
New +$167K
ACET
1466
DELISTED
Aceto Corp
ACET
$184K ﹤0.01%
17,819
-29,481
-62% -$310K
ATCO
1467
DELISTED
Atlas Corp.
ATCO
$182K ﹤0.01%
+26,589
New +$173K
WRLSW
1468
DELISTED
Pensare Acquisition Corp. Warrant
WRLSW
$179K ﹤0.01%
+345,000
New +$179K
MYOV
1469
DELISTED
Myovant Sciences Ltd.
MYOV
$175K ﹤0.01%
13,774
-11,668
-46% -$156K
LPTH icon
1470
Lightpath Technologies
LPTH
$753M
$173K ﹤0.01%
77,752
+51,142
+192% +$142K
MTL
1471
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$172K ﹤0.01%
+32,786
New +$158K
HBM icon
1472
Hudbay
HBM
$11.5B
$171K ﹤0.01%
18,933
-3,629
-16% -$28.3K
ECOM
1473
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$170K ﹤0.01%
19,013
-30,851
-62% -$305K
ZN
1474
DELISTED
Zion Oil & Gas, Inc.
ZN
$169K ﹤0.01%
+78,055
New +$191K
HIVE
1475
DELISTED
Aerohive Networks
HIVE
$168K ﹤0.01%
+28,657
New +$138K

Similar funds

Oxford Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, Oxford Asset Management held 2,053 positions worth $4.64B, down 11% from $5.19B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oxford Asset Management withdrew a net $740M in Q4 2017, closing 465 positions and reducing 586 holdings. Its most notable exit was Rice Energy Inc., an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Oxford Asset Management opened a new position in Cavium, Inc. worth $152M.

  • Oxford Asset Management's largest Q4 2017 buy was Cavium, Inc.: 1,791,008 shares worth $152M.
  • Oxford Asset Management added most to Akorn Inc in Q4 2017, an estimated $52.8M increase.
  • Oxford Asset Management's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $98.3M.
  • Oxford Asset Management fully exited Rice Energy Inc. in Q4 2017, selling an estimated $166M.
  • Oxford Asset Management's ten largest holdings make up 18% of its $4.64B portfolio in Q4 2017.
  • Oxford Asset Management opened 548 new positions and closed 465 in Q4 2017.
  • Oxford Asset Management's portfolio value fell 11% quarter-over-quarter to $4.64B.

Based on Oxford Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.